子宫内膜异位症与血清和腹膜液中染色素A及其衍生物度的增加有关
Alicja Sztokfisz-Ignasiak1,2, Maja Owe-Larsson1, Maciej Maj1
1Department of Histology and Embryology, Centre of Biostructure Research, Medical University of Warsaw, 02-004 Warsaw, Poland.
Journal of clinical medicine
|February 27, 2026
概括
子宫内膜异位症患者在血清和腹腔内液中显示出高水平的染色素A (CgA) 和其衍生物,乙胺和胰腺胺. 这些生物标志物与疾病严重程度相关,可以作为子宫内膜异位症的诊断标志物.
科学领域:
- 妇科 妇科 妇科 妇科
- 内分泌学 在内分泌学.
- 免疫学 免疫学 免疫学
背景情况:
- 子宫内膜异位症是一种常见的妇科疾病,由于子宫外内膜外损伤引起疼痛,炎症和不孕症.
- 目前的治疗方法不足,疾病的发病原因尚不清楚.
- 异位子宫内膜细胞存活率与对亡的抵抗性,免疫抑制和血管生成有关.
研究的目的:
- 为了评估血清和腹膜液中Cromogranin A (CgA) 和其衍生物,catestatin和胰岛素的度,在患有子宫内膜异位症的妇女中.
- 为了将这些水平与子宫内膜异位症疾病严重程度相关联.
- 探索CgA及其衍生物作为子宫内膜异位症诊断标记物的潜力.
主要方法:
- 从65名患有子宫内膜异位症的女性和60名对照女性中收集了血清和腹液样本.
- 使用酶相关免疫吸收试验 (ELISAs) 测量了CgA,阴位素和胰腺素度.
- 进行了统计分析,包括相关性和接收器操作特征 (ROC) 分析.
主要成果:
- 与对照人群相比,在子宫内膜异位症患者的血清和腹腔内液中发现了CgA,甲状腺素和胰腺素的显著较高度.
- 这些标志物相互关联,并与疾病进展相关.
- ROC分析表明,这些因素的高水平与子宫内膜异位症有关.
结论:
- 在子宫内膜异位症中CgA及其衍生物的升级表明它们参与了疾病的发病.
- CgA,阴位素和胰腺素显示出作为子宫内膜异位症诊断生物标志物的潜力.
- 这些分子也可能代表子宫内膜异位症治疗的未来治疗点.
关键词:
卡塔斯塔丁是指一个固剂.染色胺素A 是一种染色素.子宫内膜异位症是什么?子宫内膜异位症是什么这是一种炎症炎症炎症炎症.非侵袭性标记物的非侵袭性标记物.在胰腺中,胰腺质激素.腹腔周围的液体血液中的血清是血清.更多相关视频
07:20Intraoperative Detection of Subtle Endometriosis: A Novel Paradigm for Detection and Treatment of Pelvic Pain Associated with the Loss of Peritoneal Integrity
Published on: December 21, 2012
16.6K
14:25Assessment of Ovarian Cancer Spheroid Attachment and Invasion of Mesothelial Cells in Real Time
Published on: May 20, 2014
17.9K
相关概念视频
02:07Oogenesis
70.6K
In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...
70.6K
01:22Hormonal Regulation of the Menstrual Cycle
1.9K
The ovarian cycle regulates endometrial changes throughout a single menstrual cycle via the coordinated action of gonadotrophin-releasing hormone (GnRH) and gonadotrophins.
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
1.9K
01:27Ovarian Cycle
4.6K
The menstrual cycle includes a critical component known as the ovarian cycle, which undergoes two main phases each month—the follicular phase and the luteal phase. The follicular phase is variable and averaging around 14 days. Ovulation, triggered by a surge in luteinizing hormone (LH), marks the transition between the two phases. The second phase, the luteal phase, is relatively consistent, lasting approximately 14 days, and is marked by the activity of the corpus luteum. While a cycle...
4.6K
01:24Disorders of the Female Reproductive System
4.6K
The female reproductive system can be affected by several disorders, including Premenstrual Syndrome (PMS), Premenstrual Dysphoric Disorder (PMDD), endometriosis, and various forms of cancer. PMS and PMDD are cyclical conditions that cause physical and emotional distress, with symptoms that include edema, mood swings, and food cravings. PMDD is a more severe form of PMS characterized by increased symptom severity that peaks during the luteal phase and tends to improve or resolve shortly after...
4.6K